Synonyms: DR 3305 | PZ51 | SPI-1005
Compound class:
Synthetic organic
Comment: A synthetic organoselenium molecule with anti-inflammatory, anti-oxidant and cytoprotective activity, characterised as a small molecule Gq protein inhibitor.
Ebselen also demonstrates antimicrobial activity. A bioRxiv preprint suggests that ebselen is a low micromolar, covalent, fast-binding inhibitor of papain-like protease (PL-pro) from SARS-CoV-2 [2]. This study also reports that ebselen is less active against SARS-CoV, and binds more slowly to this enzyme homologue. Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
Ebselen has progressed to clinical evaluation. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04677972 | SPI-1005 for the Treatment of Meniere's Disease | Phase 3 Interventional | Sound Pharmaceuticals, Incorporated |